Literature DB >> 8071886

Epidermal growth factor as a diuretic in sheep.

C B Gow1, P A Phillips.   

Abstract

1. Epidermal growth factor (EGF) has recently been shown to stimulate both polydipsia and polyuria and the aim of this study was to determine which was the primary response. Ewes received a continuous intravenous saline infusion (100 ml day-1) for 12 days (days 1-12) and EGF at doses of 0 (n = 6) or 10 micrograms h-1 (n = 6) over days 5-8. The supply of water was ad libitum during days 1-4 and 9-12, but was fixed at the pretreatment mean of days 1-4 for each ewe during days 5-8. 2. During the period of fixed water intake, the EGF-treated ewes experienced mild dehydration with elevated plasma osmolality, sodium, renin and arginine vasopressin (AVP) concentrations and slightly reduced plasma atrial natriuretic peptide (ANP) concentrations. 3. When the supply of water returned to ad libitum, the EGF-treated ewes increased their water intake by 105% (5.25 +/- 0.28 vs. 2.55 +/- 0.19 l day-1) and subsequently fluid balance was restored; plasma electrolyte and hormone responses also returned to normal. 4. This experiment demonstrates that EGF infused at a dose rate of 10 micrograms h-1 I.V. into sheep has a direct renal diuretic effect.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8071886      PMCID: PMC1155571          DOI: 10.1113/jphysiol.1994.sp020168

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  18 in total

1.  Evaluation of renin and angiotensin assays and their clinical application.

Authors:  C I Johnston; F Mendelsohn; D Casley
Journal:  Med J Aust       Date:  1971-01-16       Impact factor: 7.738

2.  Hormonal, fluid, and electrolyte responses of sheep during chronic intravenous infusion of epidermal growth factor.

Authors:  C B Gow; P A Phillips; K D Chandler; G P Moore
Journal:  Am J Physiol       Date:  1993-07

3.  Vasopressin inhibition of epidermal growth factor binding to cultured mouse cells.

Authors:  E Rozengurt; K D Brown; P Pettican
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

Review 4.  Renal arachidonic acid metabolism.

Authors:  M G Currie; P Needleman
Journal:  Annu Rev Physiol       Date:  1984       Impact factor: 19.318

5.  Contribution of vasopressin to the maintenance of blood pressure during dehydration.

Authors:  R L Woods; C I Johnston
Journal:  Am J Physiol       Date:  1983-11

6.  Epidermal growth factor inhibits the hydroosmotic effect of vasopressin in the isolated perfused rabbit cortical collecting tubule.

Authors:  M D Breyer; H R Jacobson; J A Breyer
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

7.  Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues.

Authors:  L B Rall; J Scott; G I Bell; R J Crawford; J D Penschow; H D Niall; J P Coghlan
Journal:  Nature       Date:  1985 Jan 17-23       Impact factor: 49.962

8.  Plasma atrial natriuretic peptide: concentrations and circulating forms in normal man and patients with chronic renal failure.

Authors:  K Ogawa; A I Smith; G P Hodsman; B Jackson; E A Woodcock; C I Johnston
Journal:  Clin Exp Pharmacol Physiol       Date:  1987-02       Impact factor: 2.557

Review 9.  Epidermal growth factor and the kidney.

Authors:  D A Fisher; E C Salido; L Barajas
Journal:  Annu Rev Physiol       Date:  1989       Impact factor: 19.318

10.  Receptor-mediated vectorial transcytosis of epidermal growth factor by Madin-Darby canine kidney cells.

Authors:  E Maratos-Flier; C Y Kao; E M Verdin; G L King
Journal:  J Cell Biol       Date:  1987-10       Impact factor: 10.539

View more
  6 in total

1.  Targeting the Trafficking of Kidney Water Channels for Therapeutic Benefit.

Authors:  Pui W Cheung; Richard Bouley; Dennis Brown
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-09-27       Impact factor: 13.820

2.  Immunolocalization of transforming growth factor alpha in normal human tissues.

Authors:  M E Christensen; S S Poulsen
Journal:  Histochem Cell Biol       Date:  1996-05       Impact factor: 4.304

3.  EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water Reabsorption.

Authors:  Pui W Cheung; Naohiro Nomura; Anil V Nair; Nutthapoom Pathomthongtaweechai; Lars Ueberdiek; Hua A Jenny Lu; Dennis Brown; Richard Bouley
Journal:  J Am Soc Nephrol       Date:  2016-03-09       Impact factor: 10.121

4.  High-throughput chemical screening identifies AG-490 as a stimulator of aquaporin 2 membrane expression and urine concentration.

Authors:  Naohiro Nomura; Paula Nunes; Richard Bouley; Anil V Nair; Stanley Shaw; Erica Ueda; Nutthapoom Pathomthongtaweechai; Hua A Jenny Lu; Dennis Brown
Journal:  Am J Physiol Cell Physiol       Date:  2014-06-18       Impact factor: 4.249

Review 5.  Aquaporin 2 regulation: implications for water balance and polycystic kidney diseases.

Authors:  Emma T B Olesen; Robert A Fenton
Journal:  Nat Rev Nephrol       Date:  2021-07-01       Impact factor: 28.314

Review 6.  Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.

Authors:  Serena Milano; Monica Carmosino; Andrea Gerbino; Maria Svelto; Giuseppe Procino
Journal:  Int J Mol Sci       Date:  2017-11-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.